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A B S T R A C T
Background: Needle and syringe programs (NSPs) are widely used to reduce harms associated with drug
injecting. This study assessed the effect of facility-based (on-site services at drop-in centre) and outreach
models of NSP on injection risk behaviours.
Methods: Self-reported data from 455 people who injected drugs (PWID) during 2014 in Kermanshah,
Iran, were examined to measure demographic characteristics and risk behaviors. Self-reported and
program data were also assessed to identify their main source of injection equipment. Participants were
divided into three sub-groups: facility-based NSP users, outreach NSP users and non-users (comparison
group). Coarsened exact matching was used to make the three groups statistically equivalent based on
age, place of residence, education and income, and groups were compared regarding the proportion of
borrowing or lending of syringes/cookers, reusing syringes and recent HIV testing.
Results: Overall, 76% of participants reported any NSP service use during the two months prior to
interview. Only 23% (95%CI: 17–27) reported outreach NSP as their main source of syringes. Using
facility-based NSP signiﬁcantly decreased recent syringe borrowing (OR: 0.27, 95%CI: 0.10–0.70), recent
syringe reuse (OR: 0.38, 95%CI: 0.23–0.68) and increased recent HIV testing (OR: 2.60, 95%CI: 1.48–4.56).
Similar effects were observed among outreach NSP users; in addition, the outreach NSP model
signiﬁcantly reduced the chance of lending syringes (OR: 0.31, 95%CI: 0.15–0.60), compared to facility-
based NSP (OR: 1.25, 95%CI: 0.74–2.17).
Conclusion: These ﬁndings suggest that the outreach NSP model is as effective as facility-based NSP in
reducing injection risk behaviours and increasing the rate of HIV testing. Outreach NSP was even more
effective than facility-based in reducing the lending of syringes to others. Scaling up outreach NSP is an
effective intervention to further reduce transmission of HIV via needle sharing.
 2015 Elsevier B.V. All rights reserved.
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UNAIDS/WHO has reported that about 270,000 people are
living with HIV in the Middle East and North Africa (United Nations
Ofﬁce on Drugs and Crime, 2012). In Iran, HIV prevalence is low in
the general population (less than 1%), while concentrated among
people who inject drugs (PWID) (Haghdoost et al., 2011; Supreme
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and Control, 2014). There are approximately 170,000–230,000
PWID in Iran, of whom, 15% are infected with HIV (Khajehkazemi
et al., 2013; Nasirian, Doroudi, Gooya, Sedaghat, & Haghdoost,
2012). Over two-thirds of all newly identiﬁed HIV cases have been
attributed to unsafe injection (Haghdoost et al., 2011; Mirahma-
dizadeh, Majdzadeh, Mohammad, & Forouzanfar, 2009; Zamani
et al., 2010). In 2002, in order to reduce the risk and harms
associated with injection, needle and syringe programs (NSPs)
were implemented in Iran. These services are delivered through
drop-in centres (DIC) and by outreach teams to those PWID who
may have difﬁculties accessing DIC (Eshrati et al., 2008;
Mirahmadizadeh et al., 2009; Nissaramanesh, Trace, & Roberts,
2005) and are the main sources of needles and syrnges in Iran
(Noroozi et al., 2015; Supreme Council of Nationwide Planning of
HIV/AIDS Infection Prevention and Control, 2014).
NSP outreach is a community-based intervention, reaching
PWID where they live, socialize, buy or inject drugs (Needle et al.,
2005). The DICs and outreach NSP provide sterile needle and
syringes, deliver training on safe injecting practices and overdose
prevention and provide condoms and safe sex education (Mathers
et al., 2010; Needle & Coyle, 1997). Safe injection kits distributed at
each visit to an NSP, either at a DIC or via outreach, consist of 3–4
syringes, 3–4 extra needles, sterile water vials, and alcohol pads
(Vazirian et al., 2005).
The effectiveness of the two models of NSP has yet to be
evaluated in Iran. The costs of establishing and maintaining a new
NSP site are much higher than adding-on an outreach-based NSP to
an existing DIC or health facility. Some NSP sites are focused on on-
site service delivery and are much less interested in providing
outreach NSP. In part this is because of a lack of knowledge or belief
in the effectiveness of outreach activities delivered in the
community. The objective of this study was to evaluate and
compare the effectiveness of the two NSP models – on-site services
at DICs and outreach-based NSP – by examining the injecting risk
behaviors of PWID in Kermanshah, an urban setting in southwest-
ern part of Iran. Kermanshah was where the HIV epidemic ﬁrst
emerged in Iran and triggered the national response to HIV.
Methods
A cross-sectional study design was used. Participants were
recruited from the community and NSP sites between September
and December 2014. PWID from NSP sites were recruited by
convenience sampling, and in the community through outreach
and peer-referral. The outreach team regularly attended venues
where PWID congregated and they also encouraged respondents to
refer their peers to the study by distributing referral coupons.
Study inclusion criteria were males aged over 18 years of age, who
self-reported drug injection within the last month and who were
willing to provide written consent to participate in the study.
Data were collected through face-to-face interviews. The
questionnaire consisted of ﬁve sections, including demographic
information, type of drug injected most frequently, duration of
drug use and injection, frequency of injection, risk behaviours such
as sharing (borrowing or lending) syringes/needles and cookers,
reuse of syringes and number of injecting partners they had shared
syringes/needles with during the month prior to the interview.
Information about HIV testing in the past 12 months was also
requested. The content of the questionnaire was discussed with
eight experts in the ﬁelds of behavioural science, epidemiology and
harm reduction.
Our main area of enquiry was whether study participants had
used on-site or outreach NSP services as their main source of
syringes in the two months prior to interview; deﬁned as the
service where they sourced at least 70% of their injectingequipment. This was measured by the self-reported data, and
then validated by checking the DICs and outreach services’ client
monitoring information and log books. Those who reported neither
on-site nor outreach NSP as their main (70% or more) source of
syringes were assigned to the NSP non-user group. In case of
discrepancy, participants’ allocation to a sub-group was based on
service monitoring information and logbook data.
No identifying information was collected. During the consent
procedure, participants were provided with information about the
study objectives, the risks and beneﬁts of participating in the study,
and their right to withdraw from the study at any time without
penalty. The study protocol and procedures were reviewed and
approved by the Research Ethics Committee of the Kerman
University of Medical Sciences (Ethics Code: k/93/204).
Coarsened Exact Matching (CEM) is a statistical matching
technique used to improve causal inferences of observational
studies (Stuart, 2010) and is recommended when an experimental
design is not feasible (Sidney, Coberley, Pope, & Wells, 2015). Here
CEM was applied to match outreach and facility-based NSP users
and non-NSP users based on certain covariates in order to ensure
statistically equivalent comparison groups to estimate the effect of
the NSP models on injection risk behaviour. The CEM created a
comparable sub-sample of the three subgroups based on age, place
of residence, income and education level. CEM attempts to control
for the potential confounding inﬂuence of ‘pre-exposure’ covari-
ates on the outcome of interest, by matching ‘exposed’ cases with
‘non-exposed’ cases that are approximately similar with regard to
covariates (Wells et al., 2013). This approach allowed us to
designate a counterfactual for each participant in the exposed
group, i.e. outreach-based NSP, and mimic a randomized clinical
design. We chose CEM over other matching techniques, such as
propensity score matching, to achieve balanced groups, reduce the
need for multiple iterations and re-matching, and maximize the
number of possible matches in our sample. Also, the predictors for
using outreach or on-site NSP were unknown and such information
would have been crucial for applying a propensity matching
analysis (Iacus, King, & Porro, 2009; King, Nielsen, Coberley, Pope,
& Wells, 2011).
Using CEM, every study participant was allocated into one of
the speciﬁed set of strata in which all were exactly matched on a
set of coarsened or matched variables. Matched members were
then assigned a weight speciﬁc to their stratum and representative
of the proportion of all members present in that stratum (King
et al., 2011). Then, a statistical measure called L1 distance was
calculated. L1 varies between 0 and 1 and values close to zero
indicate that the matching is perfect and ensures the comparability
of the two groups (Rou, Sullivan, Liu, & Wu, 2010). The L1 was
calculated before and after applying CEM, and decreased from
0.43 to 0.00003 after coarsened exact matching. It was reassuring
that the imbalance between the two comparison groups was very
small and could be ignored. Given the matched subgroups, the
descriptive statistics for the pool sample and matched sub-sample
were reported. Logistic regression models were applied to estimate
the effect of outreach and facility-based NSP on injection risk
behaviours. The effects were reported as odds ratio (OR) and 95%
conﬁdence interval (CI). All data analyses were performed using
STATA v.11.
Results
Characteristics of study participants
A total of 455 men who injected drugs participated in the study.
The characteristics of participants in pooled (unmatched) and
matched sub-sample are presented in Table 1. The matched sample
(n = 278) had a mean age  standard deviation (SD) of 34.5  8.6
Table 3
The odds ratios for the association of the two needle and syringe distribution
models with some injection risk behaviours in the pooled (total) and matched
subsample of people who inject drugs, Kermanshah, 2014.
Behavioral outcomes Pooled sample
OR (95%CI)
Match sample
OR (95%CI)
Table 1
Characteristics of participants in the pooled (total) and matched subsample of
people who inject drugs, Kermanshah, 2014.
Variable Pooled sample
(N = 455), N (%)
Matched sample
(N = 278), N (%)
Age, year
Under 30 182(40.3) 152(54.6)
30–39 145(31.7) 82(29.5)
40–49 103(22.6) 38(13.6)
Upper 50 25(5.4) 6(2.3)
Education
Primary or below 117(23.7) 39(14.0)
High school 179(39.4) 133(47.8)
Diploma or higher 159(34.9) 106(38.2)
Current marital status
Single 268(60.2) 217(77.3)
Married 54(10.5) 18(8.5)
Divorce 79(17.3) 30(9.7)
In separation 44(9.7) 6(2.4)
Widower 10(2.3) 7(2.1)
Live with
Family 228(50.3) 148(52.5)
Friends 37(7.4) 23(8.2)
Alone 189(42.3) 107(39.3)
Monthly income
Less than $150 391(86.4) 249(87.3)
$150 or more 63(13.6) 29(10.7)
Age at ﬁrst drug injection, year
Under 25 270(60.3) 210(76.4)
25–30 104(21.4) 41(14.3)
30 or older 81(18.3) 27(9.3)
Age at ﬁrst drug use, year
Under 25 399(87.5) 254(88.5)
25–30 44(9.2) 21(8.7)
30 or older 12(3.3) 3(2.8)
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30 years old (54.6%). Also, 61.8% of participants had less than a high
school education, 77.3% were single, 52.5% lived with their families,
and 87.3% had a monthly income of less than $150. About 88.5%
reported their ﬁrst drug use, and 76.4% their ﬁrst injection, under the
age of 25 years old.
Behaviors of study participants and estimates of NSP outcomes
Overall, 76% of study participants reported any NSP service use
during the two months prior to interview and only 23% (95%CI: 17–
27) had used outreach NSP as their main source of syringes.
Table 2 shows NSP outcomes in matched and unmatched study
sub-samples. Only matched results are discussed here. Regarding
needle sharing behaviors, about 30.2% of respondents reportedTable 2
Behavioral outcomes in the pooled (total)and matched subsample of people who
inject drugs, Kermanshah, 2014.
Behavioral outcome Pooled
(N = 455),
N (%)
Matched
(N = 278),
N (%)
Ever borrowing a syringe 152(34.2) 84(30.2)
Borrowing a syringe in the past month 60(14.2) 31(12.3)
Ever lending a used syringe 145(32.4) 71(26.3)
Lending a used syringe in the past month 58(13.7) 36(13.4)
Ever borrowing or lending a cooker 329(72.4) 186(68.2)
Borrowing or lending a cooker in the past
month
253(56.5) 137(53.2)
Reuse own syringes in the past month 397(88.2) 239(86.1)
Received an HIV test in the past 12 months 390(85.2) 237(85.3)
Number of injecting partners whom shared syringes/needles or cookers within
the past month
Mean (SD) 2.88(1.7) 2.31(1.4)
Median (P25, P75) 2(0, 4) 2 (0, 4)
P, Percentile.ever borrowing a syringe and 12.3% reported recent borrowing of a
syringe. Similarly, 13.4% of participants reported recent lending of
a used syringe to other PWID. Ever and recently borrowing or
lending a cooker was more commonly reported by participants
(68.2% and 53.2%, respectively). The majority of participants
(86.1%) reported reuse of their own syringes in the month prior to
interview. The mean number of injecting partners with whom the
study participants had shared a syringe/needle or cooker with was
2.31  1.4. The majority of PWID (85.3%) reported having taken an
HIV test in the past 12 months.
In Table 3, the effect of the two NSP models is presented,
facility-based and outreach, on different injection risk behaviours
in the pooled and matched sub-samples. In the matched sub-
sample, PWID who used facility-based NSP services were less likely
to report borrowing syringes in past month (OR: 0.27, 95%CI: 0.10–
0.70, P-value: 0.04), compared to non-NSP users. Likewise, those
who used the NSP outreach services reported less recent syringe
borrowing (OR: 0.40, 95%CI: 0.28–0.81, P-value: 0.01).
Regarding recent syringe lending, the outreach NSP users were
signiﬁcantly less likely to report doing so (OR: 0.31, 95%CI: 0.15–
0.60, P-value: 0.02), than the facility-based NSP users (OR: 1.25,
95%CI: 0.74–2.17). Own syringe reuse was reported less frequently
in both the facility-based (OR: 0.38, 95%CI: 0.23–0.68, P-value:
0.03) and outreach groups (OR: 0.54, 0.30–0.92, P-value: 0.02).
Recent cooker sharing was reported less among facility-based NSP
service users (OR: 0.86, 95%CI: 0.40–1.82, P-value: 0.30) and
outreach NSP users (OR: 0.63, 95%CI: 0.47–3.38, P-value: 0.23),
however neither were statistically signiﬁcant. Both facility-based
and outreach NSPs increased the chance of recent HIV testing by
2.60 and 2.45 times, respectively.
Discussion
We found that outreach NSP is as effective as facility-based
outreach in decreasing the use of borrowed syringes, reusing one’s
own used syringes and increasing the likelihood of being tested for
HIV. Based on the behaviour of service users, outreach NSP shows aBorrowing a syringe in the past month
NSP nonusersa 1 1
Facility-based NSP users 0.36 (0.10–0.70)** 0.27 (0.10–0.70)**
Outreach NSP users 0.42 (0.21–0.62)** 0.40 (0.28–0.81)**
Lending a syringe in the past month
NSP nonusers 1 1
Facility-based NSP users 1.26 (0.74–2.15) 1.25 (0.74–2.17)
Outreach NSP users 0.34 (0.18–0.64)** 0.31 (0.15–0.60)**
Sharing a cooker in the past month
NSP nonusers 1 1
Facility-based NSP users 0.86 (0.42–1.75) 0.86 (0.40–1.82)
Outreach NSP users 0.94(0.43–2.04) 0.63(0.47–3.38)
Syringe reuse in the past month
NSP nonusers 1 1
Facility-based NSP users 0.31(0.19–0.51)** 0.38 (0.23–0.68)**
Outreach NSP users 0.44 (0.27–0.72)** 0.54 (0.30–0.92)**
HIV test in the past 12 months
NSP nonusers 1 1
Facility-based NSP users 3.32(1.90–5.76)** 2.60 (1.48–4.56)**
Outreach NSP users 2.83 (1.72–4.65)** 2.45 (1.36–4.39)**
a Reference group.
** Signiﬁcant at p < 0.05. The matched subsample was made by considering age,
place of residence, education and income.
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facility-based NSP.
Effectiveness of needle/syringe programs in reducing equip-
ment sharing among PWID has been shown in previous studies
(Islam, Wodak, & Conigrave, 2008; Kral, Anderson, Flynn, &
Bluthenthal, 2004; Kwon, Iversen, Maher, Law, & Wilson, 2009;
Mathers et al., 2010). There are several methods for distribution,
sale or exchange of injecting equipment, including conventional
NSPs (facility-based NSP), pharmacy-based distribution and
outreach programmes. NSP services through outreach can be
provided at locations and times that are convenient for PWID and
so increase access to NSP services (Islam & Conigrave, 2007). This
can also improve coverage for PWID who face structural and
cultural barriers to using ﬁxed site services (Abdala, Crowe,
Tolstov, & Heimer, 2004).
There are limited data on the efﬁcacy of different delivery
methods for NSP and their effect on preventing HIV risk behaviours
(Jones, Pickering, Sumnall, McVeigh, & Bellis, 2010). We found that
the majority of the PWID had access and used either one of the NSP
delivery models. However, only one-quarter reported outreach
NSP as their main source of injection equipment. This suggests that
there is a room to improve and scale up NSP services through
outreach. The results of matched analysis showed that injection
high-risk behaviours are relativity common in PWID, no matter
which service they attend. Our results are consistent with those
reported in other studies (Khajehkazemi et al., 2013; Rahimi-
Movaghar, Amin-Esmaeili, Haghdoost, Sadeghirad, & Mohraz,
2012; Sajadi et al., 2013). In 2010, Sajadi et al. found that 12.6%
of PWID in Iran shared needles and syringes (Sajadi et al., 2013).
We found that the most commonly shared injection equipment
was cookers. The high rate of cooker sharing has also been reported
elsewhere. In a study of PWID in Wales (UK) in 2010, paraphernalia
(cooker) sharing was reported by 67% of participants (Coates,
Richter, & Caceres, 2008). Zamani et al. in 2010 reported that 32% of
injecting drug users in Isfahan shared cookers (Kai Wang,
Longﬁeld, Modi, Mundy, & Firestone, 2014).
We found both facility-based and outreach NSP models were
effective in reducing injection risk behaviours. Increasing the
number of distributed syringes/needles, scaling up second-hand
distribution, expanding the coverage of services and establishing
NSP in high-risk neighbourhoods and venues where PWID
gather has been shown to reduce risk behaviours (Foss, Hossain,
Vickerman, & Watts, 2007). Such comprehensive intervention
packages have been shown to be effective in developed settings
such as in San Francisco and Montreal, where the risk of HIV
transmission among PWID has decreased over time by scaling
up NSP services (Mathers et al., 2010; Vickerman et al., 2006). In
2007, Islam et al. demonstrated that ﬁxed-site NSP and outreach
programs are effective in reaching, referring and providing
services that can lead to reduced HIV-related risk (Islam &
Conigrave, 2007). Rhodes et al. (2004) who studied injecting
equipment sharing among PWID in Russia, showed that PWID
who reported NSP or outreach as their main source of new
needles and syringes, were less likely to share compared to
those obtaining them from a pharmacy or shop (Needle & Coyle,
1997).
We found that not only did NSPs improve injection risk
behaviour, but also, use of either model of NSP was associated with
a higher uptake of HIV testing. Ever HIV testing was reported to be
as low as 60% in 2004 among 105 injecting drug users recruited in
Tehran (Vazirian et al., 2005) and at 49.8% in a national surveillance
survey of PWID in 2010 (unpublished data). Such outreach
programs then, offer an important opportunity to provide
condoms, information and referral of PWID to community-based
HIV testing and counselling and general health services (Schu-
macher, Fischer, & Hz, 2007). A study in southern China found thatreferral for HIV testing does increase the uptake of HIV testing
among PWID (Kai Wang et al., 2014).
We found that outreach NSP was more effective in reducing the
lending of syringes. In 2002, Obadia reported that outreach users
were signiﬁcantly less likely to share syringes, cookers and
solutions during the previous six months compared to non-
users(Obadia, Feroni, Perrin, Vlahov, & Moatti, 1999). Miller et al.
also reported that needle lending was lower among users of
outreach services compared to users of ﬁxed-site or pharmacy-
based NSP (Miller et al., 2002). The lower rates of syringe lending
among users of outreach services might be explained by their
higher frequency of injection; also reported in other studies (Fung
et al., 2007). We found that the injection rate (per week) of those
using outreach NSP was higher than users of NSP on-site facilities
and given the number of distributed syringes per visit is the same
at both NSP models, outreach NSP users may be less willing to lend
their injection equipment. Another explanation relates to the
nature of NSP outreach delivery – all PWID are presented with their
injection equipment at the same time so everybody receives a
sufﬁcient number of syringes, suggesting that there is no need to
lend injection equipment to others. In contrast, the on-site model
has a more individual-based approach, with one person served at a
time and where a client who has received equipment could feasibly
be asked by others to share.
There are some limitations to our study. We used a mix of
recruitment strategies to locate and recruit eligible participants;
the diversity of our sample might be comprehensive enough for
Kermanshah but it is not a truly random sample of the PWID
population. Like any other observational study, we can only report
the association of program exposure with high-risk behaviours.
Furthermore, our data were based on participants self-report and
therefore this may be subject to recall and social desirability bias
(Latkin & Vlahov, 1998). We made the two groups comparable
based on matching of age, income, education and city of residence,
however we could not account for other factors such as distance to
NSP facilities, availability of methadone maintenance therapy and
other individual factors.
In conclusion, less than one-quarter of PWID had their main
access to NSP services through outreach services. Given that the
effect of outreach NSP was found to be equivalent to on-site NSP
services, scaling up of outreach NSP to improve coverage is
arguably an effective and cost efﬁcient strategy to reach the
population of injecting drug users in Kermanshah and to reduce
transmission of HIV in this setting.
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